Clinical Trials List
2023-03-01 - 2024-03-29
Phase I/II
Not yet recruiting1
Recruiting3
-
Trial Applicant
OBI PHARMA, INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chen-Yuan Lin Division of Hematology & Oncology
- 王秀慈 Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 黃文冠 Division of General Surgery
- Jen-Shi Chen Division of General Surgery
- 曾振輝 Division of General Surgery
- 黃培青 Division of General Surgery
- 吳教恩 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 劉奕廷 Division of Hematology & Oncology
- Chien-Jui Huang Division of Hematology & Oncology
- 顏志傑 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ta-Chung Chao Division of Hematology & Oncology
- Chun-Yu Liu Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
32 participants
-
Global
101 participants
